CPC A61K 38/2086 (2013.01) [A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/215 (2013.01); A61K 31/4045 (2013.01); A61K 31/4406 (2013.01); A61K 31/506 (2013.01); A61K 35/17 (2013.01); A61K 39/12 (2013.01); C07K 14/70535 (2013.01); C07K 16/1063 (2013.01)] | 20 Claims |
1. A treatment kit for use in reducing a latent viral reservoir in an HIV infected individual, the kit comprising ALT-803 and a histone deacetylase (HDAC) inhibitor;
wherein the ALT-803 and the HDAC inhibitor are present in sufficient quantity to trigger, upon administration to the individual, expression of viral antigens in the HIV infected cell.
|